Interval debulking surgery, or IDS, is a way to treat advanced – meaning stage III or IV – ovarian cancer when primary surgery isn’t possible. IDS also can be performed as a secondary surgery when ...

National guidelines recommend primary surgery as the preferred initial treatment for advanced ovarian cancers despite studies showing less perioperative morbidity with neoadjuvant chemotherapy ...

Michael J. Worley, Jr., MD, Director of Ovarian Cancer Surgery at Brigham and Women’s Hospital in Boston, provides an update on identifying the subset of patients who are most likely to benefit from ...

Effect of weekly administration of bevacizumab, eribulin, and oxalilplatin in patients with heavily pretreated serous ovarian carcinoma. This is an ASCO Meeting Abstract from the 2013 ASCO Annual ...

The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer reviewed. Survival outcomes for patients with high-grade serous ovarian carcinoma may be ...

Significant disparities exist in the adoption of minimally invasive interval debulking surgery for advanced ovarian cancer, with gaps potentially widening as the procedure becomes more common.